Journal list menu
IssueCancer Communications: Volume 44, Issue 11
1229-1378November 2024
Export Citations
Download PDFs
ISSUE INFORMATION
ORIGINAL ARTICLE
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma
- Pages: 1231-1260
- First Published: 02 September 2024
Tryptophan 2,3-dioxygenase-positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine-mediated ferroptosis resistance of metastatic cells and T cell dysfunction
- Pages: 1261-1286
- First Published: 02 September 2024
Local TSH/TSHR signaling promotes CD8+ T cell exhaustion and immune evasion in colorectal carcinoma
- Pages: 1287-1310
- First Published: 16 September 2024
LETTER TO THE JOURNAL
Single-cell transcriptomic atlas reveals immune and metabolism perturbation of depression in the pathogenesis of breast cancer
- Pages: 1311-1315
- First Published: 19 September 2024
REVIEW
Altered glycosylation in cancer: molecular functions and therapeutic potential
- Pages: 1316-1336
- First Published: 21 September 2024
ORIGINAL ARTICLE
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial
- Pages: 1337-1349
- First Published: 25 September 2024
Yap methylation-induced FGL1 expression suppresses anti-tumor immunity and promotes tumor progression in KRAS-driven lung adenocarcinoma
- Pages: 1350-1373
- First Published: 28 September 2024
LETTER TO THE JOURNAL
Deciphering protective genomic factors of tumor development in pediatric Down syndrome via deep learning approach to whole genome and RNA sequencing
- Pages: 1374-1378
- First Published: 10 October 2024
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)